HALISTER: Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart

Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart

Alert: HALISTER
Source: BN (Bloomberg News)

Tickers
MRK US (Merck & Co Inc)
BING GR (Boehringer Ingelheim GmbH)
LLY US (Eli Lilly & Co)

People
Charles Butler (Guggenheim Securities LLC)
Pamela Eisele (Merck & Co Inc)
Steven Nissen (Cardiovascular Medicine PC)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283